GaBI Online aims to be a one-stop portal containing news, a repository of worldwide guidelines and an archive of related scientific information. It seeks to provide readers with the latest updates on developments in generic and biosimilar medicines, and to serve as a communication vehicle to reach key members of the healthcare world.
GaBI Online subscribers can stay informed by receiving weekly online alerts on the latest news on generic and biosimilar medicines from different perspectives covering information on research and general news, policies and legislation, worldwide guidelines, scientific and interview reports, news and reports of major conferences and events.
The mission of GaBI Journal (official Journal of the Generics and Biosimilars Initiative) is to provide an independent, high quality, authoritative, and peer reviewed platform for the publication of scientific articles concerning any aspect of the research into and development of cost-effective medicines, irrespective of their source.
GaBI Journal strives to satisfy the needs of a wide readership, offering high quality relevant reports, studies, analyses and updates on issues of interest to healthcare practitioners, policymakers and drug developers.
GaBI Journal – print ISSN: 2033-6403; online ISSN: 2033-6772
Biosimilars for Healthcare Professionals
Biosimilarity and Interchangeability
Generic Immunosuppressants in Transplantation
Non-Biological Complex Drugs
INN for biosimilars
GaBI Educational Workshops / Meetings
GaBI educational workshops aim to provide training opportunities in focus topics identified by members of the Journal’s editorial boards, reflecting the current educational needs of the target audience.
In 2013, GaBI organized the First Asia-Pacific Educational Workshop on Non-Biological Complex Drugs on 8 October 2013 in Kuala Lumpur, Malaysia.
This educational workshop intends to raise awareness to healthcare providers and regulators on the efficacy, safety and quality nature of follow-on non-biological complex drugs, subsequently they can build recommendations in the regulatory requirements on and approval of these follow-on medicinal products.
Representatives from regulatory authorities, academia, medical specialists will join together in this educational workshop to foster open discussions on the issues surrounding interchangeability and substitution of these medicines.
Click here to view the event photos.